Gujarat Themis Biosyn Ltd
GUJTHEMA daily price is not collected for this company, as it is not a constituent of an index the platform tracks. The records below are the disclosures the exchange has published against it.
Counterparties, netted
1 party disclosed across these transactions. 1 appeared on both sides, so the disclosures net closer to flat than their count suggests.
| Counterparty | Disclosures | Buy | Sell | Net · ₹ Cr |
|---|---|---|---|---|
| L7 HITECH PRIVATE LIMITEDBoth sides | 2 | 1 | 1 | −27 |
Net is purchases less sales across the disclosures collected, using the values the exchange published. It is arithmetic on what was disclosed, not a statement about why any party transacted.
Disclosed transactions
2 disclosed transactions across 1 session: 1 purchase, 1 sale
| Counterparty | Side | Quantity | Price | Value |
|---|---|---|---|---|
| 23 September 2026 | −₹27 Cr | |||
| L7 HITECH PRIVATE LIMITEDbulk | SELL | 6,53,056 | ₹410.72 | ₹27 Cr |
| L7 HITECH PRIVATE LIMITEDbulk | BUY | 100 | ₹413.37 | ₹0 Cr |
Substantial acquisitions
1 SEBI SAST filing
| Disclosed | Acquirer | Action | Route | Change | Holding after |
|---|---|---|---|---|---|
| 2026-09-03 | Pharmaceutical Business Group India Ltd, Themis Medicare Limited, Dinesh Shantilal Patel, Jayshree D Patel, Reena S Patel, Sachin Dinesh Patel, Dinesh Shantilal Patel, Anay Rupen Choksi, Nysha Rupen Choksi and Dinesh S Patel (Vividhmargi Trust)promoter | Acquisition | Others | n.a. | 59.33% |
Prices sourced from Yahoo Finance ↗. Transactions and SAST filings sourced from the National Stock Exchange ↗. No content on this page constitutes a recommendation, and no entry is inferred. Every line records a disclosure made by a publishing authority.